MyoStress™, a rapid stress test utilizing breathing maneuvers, has continued to demonstrate excellent accuracy at detecting ischemic coronary artery disease without the need for pharmacologic stress agents or contrast injections in this new publication from University of Heidelberg...
Myocardial Solutions, Inc. (MSI) released a new software version in the United States much like version 5.2.4 for the European Market. The updated software features...
Dr. Melgar presented five cases where she demonstrated the clinical value of MyoStrain® over traditional metrics and current standard of care protocols. She evaluated and explained how MyoStrain provides additional information when making treatment decisions. In all five cases...
Myocardial Solutions, Inc. (MSI) announced the opening of the first MyoStrain Cardio-Oncology Center in Madrid. The Center represents a partnership between MSI and Vithas Group (Vithas), a chain of Spanish...
Myocardial Solutions released a new software version of MyoStrain® with a primary new function feature enabling semi-auto contouring of cardiac images...
